Berlin, Germany

Alexander Scheffold

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander Scheffold: Innovator in T-Cell Immunology

Introduction

Alexander Scheffold is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of immunology, particularly in the identification of T-cell stimulating protein fragments. His innovative approach has the potential to enhance immunostimulation therapies.

Latest Patents

Scheffold holds a patent for a method that identifies T-cell stimulating protein fragments. The patent outlines a systematic approach that includes detecting the amino acid sequence of an antigen, subdividing it into protein fragments, synthesizing these fragments, and incubating them with T-cells. The method culminates in identifying induced T-cell cytokines or activation markers through flow-through cytometry. This invention is crucial for developing medicaments aimed at immunostimulation.

Career Highlights

Throughout his career, Alexander Scheffold has focused on advancing immunological research. His work has led to the development of innovative methods that can significantly impact therapeutic strategies in immunology. His dedication to research and innovation has established him as a key figure in his field.

Collaborations

Scheffold has collaborated with esteemed colleagues such as Rainer Blasczyk and Peter Walden. These partnerships have fostered a collaborative environment that enhances the research and development of immunological therapies.

Conclusion

Alexander Scheffold's contributions to immunology through his innovative patent demonstrate his commitment to advancing medical science. His work in identifying T-cell stimulating protein fragments holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…